Brammer Bio, a contract development and manufacturing organization (CDMO) for companies developing gene-modified cell therapies and in vivo gene therapies, has made leadership appointments to support the growth of the organization.   Steve Falcone joins Brammer as chief quality officer, reporting directly to Brammer’s president and chief executive officer, Mark Bamforth. Steve brings 22 years of industry experience, most recently from Sanofi where he was overseeing quality for three comm...